Journal of Radiopharmaceuticals and Molecular Probes (대한방사성의약품학회지)

Korean Society of Radiopharmaceuticals and Molecular Probes (대한방사성의약품학회)
권호 표지
DOI QR코드

DOI QR Code

Molar activity of radiopharmaceuticals

  • Choe, Yearn Seong (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea and Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University)
  • Received : 2018.06.08
  • Accepted : 2018.06.23
  • Published : 2018.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Radiopharmaceuticals are used for diagnosis or therapy of diseases. According to the recent consensus nomenclature rules for radiopharmaceutical chemistry, specific activity is defined as the radioactivity per gram of radiolabeled compound and molar activity as the radioactivity per mole of radiolabeled compound. In this review, molar activity of radiopharmaceuticals is discussed in terms of its significance in nuclear imaging as well as its measurement methods.

최근에 보고된 방사성의약품화학 분야의 명명법에 따라 그 동안 specific activity로 정의하였던 개념을 물리적인 성질을 나타내는 specific activity와 화학적 성질을 나타내는 molar activity로 세분하였다(1). 이 종설에서는 방사성의약품의 molar activity 및 중요성 등을 알아보았으며, 방사성의약품을 합성할 때 중요하게 고려하여야 한다.

Keywords

References

  1. Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight. Nucl Med Biol 2017;55:v-xi. https://doi.org/10.1016/j.nucmedbio.2017.09.004
  2. Schlyer DJ. PET tracers and radiochemistry. Ann Acad Med Singapore 2004;33:146-154.
  3. Berridge MS, Apana SM, Hersh JM. Teflon radiolysis as the major source of carrier in fluorine-18. J Label Compd Radiopharm 2009;52:543-548. https://doi.org/10.1002/jlcr.1672
  4. Sihver W, Langstrom B, Nordberg A. Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain. Acta Neurol Scand 2002;Suppl 176:27-33.
  5. Villemagne VL, Horti A, Scheffel U, Ravert HT, Finley P, Clough DJ, London ED, Henry N. Wagner, Jr HN,Dannals RF. Imaging nicotinic acetylcholine receptors with fiuorine-18-FPH: an epibatidine analog. J Nucl Med 1997;38:1737-1741.
  6. Van Daele PG, De Bruyn MF, Boey JM, Sanczuk S, Agten JT, Janssen PA. Synthetic analgesics: N-(1-[2-arylethyl]-4-substituted 4-piperidinyl) N-arylalkanamides. Arzneim-Forsch (Drug Res). 1976;26:1521-1531.
  7. Blecha JE, Henderson BD, Hockley BG, VanBrocklin HF, Zubieta JK, DaSilva AF, Kilbourn MR, Koeppe RA, Scott PJH, Shao X. An updated synthesis of $[^{11}C]$ carfentanil for positron emission tomography (PET) imaging of the ${\mu}-opioid$ receptor. J Label Compd Radiopharm 2017;60:375-380. https://doi.org/10.1002/jlcr.3513
  8. Monographs on radiopharmaceutical preparations and starting materials for radiopharmaceutical preparations.In: Council of Europe. European Pharmacopoeia. 9th ed. Vol. I. Strasbourg. 2017. p. 1125-1204.